BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 2, 2001
View Archived Issues
Antisense oligonucleotide targeting PTP1B effective in animal models of diabetes, insulin resistance
Read More
Further results for NN-2211 continue to support its potential in type 2 diabetes
Read More
Dual-acting PPARgamma/PPARalpha agonist NNC-61-0029/(-)-DRF-2725: pharmacology and clinical PK
Read More
Adolor's opioid narcotic antagonist completes phase II trials for two indications
Read More
Crucell and Vaxin to jointly develop new noninvasive antiviral vaccines
Read More
BIBN-4096BS is a functionally selective CGRP receptor antagonist with potential in migraine Rx
Read More
AGY Therapeutics enters several alliances to identify drug targets for CNS diseases and obesity
Read More
Prophylaxis of refractory migraine with levetiracetam discussed at IHC 2001
Read More
ISTA completes enrollment in phase III study of Vitrase
Read More
TLK-286 enters phase II trial for non-small cell lung cancer
Read More
Pharmacological profile of a new ACAT inhibitor: R-755
Read More
Novirio establishes marketing agreement for LdT with Sumitomo
Read More
Phase III clinical trials of CV Therapeutics' CVT-510 commence
Read More
Matrix commences new phase II IntraDose study for primary liver cancer
Read More
Potential of topiramate for diabetes explored using animal models
Read More
Tetrahydroisoquinolines particularly useful in ADHD according to DuPont
Read More
New inhibitors of PDGF receptor autophosphorylation designed at JT
Read More
Newest factor Xa inhibitors and use in thromboembolic disorders reported by DuPont
Read More
COX-2-selective antiinflammatory, antiphlogistic and analgesic series claimed by Theramex
Read More
Mode of action of Oxigene's CA4P supported by preclinical data
Read More
Novel antiherpesvirus agents in the GSK pipeline
Read More
MacroChem completes phase III trial of Topiglan for treatment of ED
Read More
Adjunctive therapy with tizanidine for migraine prophylaxis
Read More
Allergan and Inspire collaborate on development of two ophthalmic products for dry eye
Read More
FDA grants fast track designation for irofulven in pancreatic cancer
Read More